Seeking Alpha

Mylan (MYL -0.4%) says its partner Famy Care has received final FDA approval for its Abbreviated...

Mylan (MYL -0.4%) says its partner Famy Care has received final FDA approval for its Abbreviated New Drug Application for Levonorgestrel and Ethinyl Estradiol Tablets, a generic version of Teva Pharmaceutical's (TEVA +0.6%) contraception product Nordette. MYL plans to begin shipping the product immediately.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector